The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease

Androgens have diverse functions in muscle physiology, lean body mass, the regulation of adipose tissue, bone density, neurocognitive regulation, and spermatogenesis, the male reproductive and sexual function. Male hypogonadism, characterized by reduced testosterone, is commonly seen in ageing males...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kristian Leisegang, Shubhadeep Roychoudhury, Petr Slama, Renata Finelli
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/9de7509ad33e4594b1080f8d6ae50f73
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9de7509ad33e4594b1080f8d6ae50f73
record_format dspace
spelling oai:doaj.org-article:9de7509ad33e4594b1080f8d6ae50f732021-11-25T16:29:29ZThe Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease10.3390/antiox101118342076-3921https://doaj.org/article/9de7509ad33e4594b1080f8d6ae50f732021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1834https://doaj.org/toc/2076-3921Androgens have diverse functions in muscle physiology, lean body mass, the regulation of adipose tissue, bone density, neurocognitive regulation, and spermatogenesis, the male reproductive and sexual function. Male hypogonadism, characterized by reduced testosterone, is commonly seen in ageing males, and has a complex relationship as a risk factor and a comorbidity in age-related noncommunicable chronic diseases (NCDs), such as obesity, metabolic syndrome, type 2 diabetes, and malignancy. Oxidative stress, as a significant contributor to the ageing process, is a common feature between ageing and NCDs, and the related comorbidities, including hypertension, dyslipidemia, hyperglycemia, hyperinsulinemia, and chronic inflammation. Oxidative stress may also be a mediator of hypogonadism in males. Consequently, the management of oxidative stress may represent a novel therapeutic approach in this context. Therefore, this narrative review aims to discuss the mechanisms of age-related oxidative stress in male hypogonadism associated with NCDs and discusses current and potential approaches for the clinical management of these patients, which may include conventional hormone replacement therapy, nutrition and lifestyle changes, adherence to the optimal body mass index, and dietary antioxidant supplementation and/or phytomedicines.Kristian LeisegangShubhadeep RoychoudhuryPetr SlamaRenata FinelliMDPI AGarticleantioxidantsnoncommunicable chronic diseasenutritionphytonutrientstestosteronetestosterone replacement therapyTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1834, p 1834 (2021)
institution DOAJ
collection DOAJ
language EN
topic antioxidants
noncommunicable chronic disease
nutrition
phytonutrients
testosterone
testosterone replacement therapy
Therapeutics. Pharmacology
RM1-950
spellingShingle antioxidants
noncommunicable chronic disease
nutrition
phytonutrients
testosterone
testosterone replacement therapy
Therapeutics. Pharmacology
RM1-950
Kristian Leisegang
Shubhadeep Roychoudhury
Petr Slama
Renata Finelli
The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
description Androgens have diverse functions in muscle physiology, lean body mass, the regulation of adipose tissue, bone density, neurocognitive regulation, and spermatogenesis, the male reproductive and sexual function. Male hypogonadism, characterized by reduced testosterone, is commonly seen in ageing males, and has a complex relationship as a risk factor and a comorbidity in age-related noncommunicable chronic diseases (NCDs), such as obesity, metabolic syndrome, type 2 diabetes, and malignancy. Oxidative stress, as a significant contributor to the ageing process, is a common feature between ageing and NCDs, and the related comorbidities, including hypertension, dyslipidemia, hyperglycemia, hyperinsulinemia, and chronic inflammation. Oxidative stress may also be a mediator of hypogonadism in males. Consequently, the management of oxidative stress may represent a novel therapeutic approach in this context. Therefore, this narrative review aims to discuss the mechanisms of age-related oxidative stress in male hypogonadism associated with NCDs and discusses current and potential approaches for the clinical management of these patients, which may include conventional hormone replacement therapy, nutrition and lifestyle changes, adherence to the optimal body mass index, and dietary antioxidant supplementation and/or phytomedicines.
format article
author Kristian Leisegang
Shubhadeep Roychoudhury
Petr Slama
Renata Finelli
author_facet Kristian Leisegang
Shubhadeep Roychoudhury
Petr Slama
Renata Finelli
author_sort Kristian Leisegang
title The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
title_short The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
title_full The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
title_fullStr The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
title_full_unstemmed The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
title_sort mechanisms and management of age-related oxidative stress in male hypogonadism associated with non-communicable chronic disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9de7509ad33e4594b1080f8d6ae50f73
work_keys_str_mv AT kristianleisegang themechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT shubhadeeproychoudhury themechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT petrslama themechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT renatafinelli themechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT kristianleisegang mechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT shubhadeeproychoudhury mechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT petrslama mechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
AT renatafinelli mechanismsandmanagementofagerelatedoxidativestressinmalehypogonadismassociatedwithnoncommunicablechronicdisease
_version_ 1718413154111717376